Royalty Pharma-2026-JPM.pdf

1、J.P.Morgan Healthcare ConferenceJanuary 13,2026This presentation has been prepared by Royalty Pharma plc(the“Company”),is made for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy securities.The information set forth herein does not purport to

2、 be complete or to contain all of the information you may desire.Statements contained herein are made as of the date of this presentation unless stated otherwise,and neither the delivery of this presentation at any time,nor any sale of securities,shall under any circumstances create an implication t

3、hat the information contained herein is correct as of any time after such date or that information will be updated or revised to reflect information that subsequently becomes available or changes occurring after the date hereof.This presentation contains statements that constitute“forward-looking st

4、atements”as that term is defined in the United States Private Securities Litigation Reform Act of 1995,including statements that express the Companys opinions,expectations,beliefs,plans,objectives,assumptions or projections regarding future events or future results,in contrast with statements that r

5、eflect historical facts.Examples include discussion of Royalty Pharmas strategies,financing plans,growth opportunities and market growth.In some cases,you can identify such forward-looking statements by terminology such as“may,”“might,”“will,”“should,”“expects,”“plans,”“anticipates,”“believes,”“esti

6、mates,”“target,”“forecast,”“guidance,”“goal,”“predicts,”“project,”“potential”or“continue,”the negative of these terms or similar expressions.Forward-looking statements are based on managements current beliefs and assumptions and on information currently available to the Company.However,these forward